Feasibility of At-Home Virological and Serological Testing for SARS-CoV-2 in Children-Reference-Cited by-同舟云学术

Feasibility of At-Home Virological and Serological Testing for SARS-CoV-2 in Children

Published:2022-09-01 Issue:9 Volume:9 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Ahmed Amina¹,Rossman Whitney²,Lu Lauren C²,Dunn Connell O³,Harris Anna M²,Priem Jennifer S²,Hetherington Timothy C²,Porzucek Abigail J⁴,Mores Christopher N⁴,Castri Paola⁵,Lagarde William H⁶,Dantuluri Keerti L¹,

Affiliation:

1. Department of Pediatrics (Infectious Diseases) at Levine Children's Hospital, Atrium Health , Charlotte, North Carolina , USA

2. Center for Outcomes Research and Evaluation, Atrium Health , Charlotte, North Carolina , USA

3. Department of Emergency Medicine Research, Atrium Health , Charlotte, North Carolina , USA

4. Milken Institute School of Public Health, The George Washington University , Washington, DC , USA

5. Atrium Health Wake Forest Baptist Health , Winston Salem, North Carolina , USA

6. Wake Med Health and Hospitals , Raleigh, North Carolina , USA

Abstract

Abstract Longitudinal virological and serological surveillance is essential for understanding severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) transmission among children but requires increased test capacity. We assessed the uptake of serial at-home testing in children (2–17 years) via mailed SARS-CoV-2 antibody and molecular tests. Completion rates demonstrated the feasibility and sustainability of at-home testing across age groups.

Funder

Coronavirus Aid

North Carolina Department of Health and Human Services

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofac459/45743818/ofac459.pdf

Reference14 articles.

1. Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study;Waterfield;Arch Dis Child,2021

2. A cross-sectional investigation of SARS-CoV-2 seroprevalence and associated risk factors in children and adolescents in the United States;Levorson;PLoS One,2021